StockWatch
·

Suven Pharmaceuticals Ltd

BSE: 543064

values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-83.51161.82407.14652.47Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Margin Trend

percentage
OPM %NPM %
-4.239.0922.4235.74Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
PeriodQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25
INCOME
Revenue359.89-36.6%567.55+17.9%481.58-3.3%497.79+2.9%483.58+46.5%330.17+19.9%275.39+16.7%236.06
Other Income12.16+1639.2%-0.79-112.9%6.12-76.7%26.30+100.8%13.10+97.6%6.63-56.3%15.18+13.0%13.43
Total Income372.05-34.4%566.76+16.2%487.70-6.9%524.09+5.5%496.68+47.5%336.80+15.9%290.57+16.5%249.49
EXPENSES
Expenditure369.84-25.1%493.81+18.3%417.41+3.5%403.37-3.4%417.54+48.9%280.48+59.4%175.97+18.3%148.81
Tax0.80-96.3%21.88+20.6%18.14-31.4%26.43+43.1%18.47+54.2%11.98-57.6%28.25+16.0%24.35
PROFIT
PBT2.21-96.1%56.44-13.7%65.43-45.8%120.72+69.9%71.04+26.1%56.32-50.9%114.60+13.8%100.68
Net Profit1.41-95.9%34.56-26.9%47.29-49.8%94.29+79.4%52.57+18.6%44.34-48.7%86.35+13.1%76.33
KEY METRICS
OPM %7.36%-10.27pp17.63%-2.70pp20.33%-5.96pp26.29%+6.42pp19.87%-0.48pp20.35%-9.93pp30.28%-0.85pp31.13%
NPM %0.38%-5.72pp6.10%-3.60pp9.70%-8.29pp17.99%+7.41pp10.58%-2.59pp13.17%-16.55pp29.72%-0.87pp30.59%
EPS0.04-95.6%0.90-27.4%1.24-49.6%2.46+78.3%1.38-20.7%1.74-48.7%3.39+13.0%3.00

Corporate Events

Board MeetingCOHANCE
2026
6Nov

Board Meeting

The meeting of the Board of Directors will be held to consid…

BSE Filing ↗
Board MeetingCOHANCE
2026
9Oct

Board Meeting

The Nomination and Remuneration Committee of the Company app…

BSE Filing ↗
Board MeetingCOHANCE
2026
17Sep

Board Meeting

The Eighth Annual General Meeting of the Members of Cohance …

BSE Filing ↗
Board MeetingCOHANCE
2026
3Sep

Board Meeting

The Investment, Banking and Authorisations Committee (IBA Co…

BSE Filing ↗
Board MeetingCOHANCE
2026
5Aug

Board Meeting

The meeting of the Board of Directors will be held to consid…

BSE Filing ↗
Board MeetingCOHANCE
2026
23Jul

Board Meeting

The Nomination and Remuneration Committee approved the in-pr…

BSE Filing ↗
Board MeetingCOHANCE
2025
12Nov

Board Meeting

Board Meeting

BSE Filing ↗
Board MeetingCOHANCE
2024
12Nov

Board Meeting

Consider and approve the Un-audited Financial Results (Stand…

BSE Filing ↗
Board MeetingCOHANCE
2024
5Feb

Board Meeting

To consider and approve Un-audited Financial Results (Standa…

BSE Filing ↗
Board MeetingCOHANCE
2023
9Nov

Board Meeting

To consider and approve the Un-audited Financial Results (St…

BSE Filing ↗
Board MeetingCOHANCE
2023
8Aug

Board Meeting

Consider and approve the Un-audited Financial Results (Stand…

BSE Filing ↗